Clinical Research Informer

Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)

Rethinking Clinical Trials

NOVEMBER 1, 2022

Duke Clinical Research Institute. On March 21, 2020, in response to the COVID-19 pandemic, PCORI contacted leadership at Duke Clinical Research Institute and PCORnet and a decision was made to focus on the space of healthcare workers. Associate Professor. Duke University School of Medicine. Russell Rothman, MD, MPP.

Trials

Trials Clinical Research Vaccination Vaccine

Grand Rounds September 22, 2023: Integrating Community Health Workers into Team-Based, Early Childhood Preventative Care (Tumaini Rucker Coker, MD, MBA)

Rethinking Clinical Trials

SEPTEMBER 28, 2023

Based on these findings, the research team initiated a larger PARENT trial that had 3 parent coaches at federally qualified health centers. The research team is in the next phase of local adaptation, having received funding from PCORI for PARENT Adaptation for Black Families: NCH-PCN Partnership.

Trials

Trials Clinical Trials Clinical Trials Research

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Rethinking Clinical Trials

OCTOBER 26, 2023

There are possible clinical research components that would include research on treatment during pregnancy, vaccine development, and implementation model research. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020.

Clinical Research

Clinical Research Clinical Trials Clinical Trials Research

Grand Rounds August 19, 2022: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield, MD, MPH; Michelle Kelsey, MD)

Rethinking Clinical Trials

AUGUST 23, 2022

The Duke Clinical Research Institute (DCRI) organized and sponsored a Think Tank to address diversity in clinical trial research. The Duke Clinical Research Institute (DCRI) organized and sponsored a Think Tank to address diversity in clinical trial research. Duke University School of Medicine. Diversity, Inclusion.

Clinical Trials

Clinical Trials Clinical Trials Trials Medicine

Grand Rounds June 30, 2023: Decentralized Trials – From Guidance to Reality & What’s Left (Adrian Hernandez, MD, MHS; Pamela Tenaerts, MD, MPH; Craig Lipset, MPH)

Rethinking Clinical Trials

JULY 6, 2023

The DCT space is evolving and will require more commentary on guidance, sharing research, and effective implementation. DCTs can make things easier for patients and the research more efficient. Learn more Read more about Decentralized Clinical Trials.

Trials

Trials Clinical Trials Clinical Trials Licensing

Grand Rounds August 4, 2023: AI & ML: Want to Play a Game? (Eric Perakslis, PhD)

Rethinking Clinical Trials

AUGUST 10, 2023

What is going to keep AI in the boundaries for health hand research right now? The bleeding edge of these technologies is human talent, so if you’re struggling to keep up in this space, hire smart people. Do you think AI within the context of health and research will be replacing people? People need to be really focused.

Clinical Trials

Clinical Trials Clinical Trials Trials Medicine

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Rethinking Clinical Trials

AUGUST 28, 2023

Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. I think collectively, we want to promote the utilization of health care in research.

Clinical Trials

Clinical Trials Clinical Trials Trials Development

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Rethinking Clinical Trials

AUGUST 28, 2023

Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. I think collectively, we want to promote the utilization of health care in research.

Clinical Trials

Clinical Trials Clinical Trials Trials Development

Google’s 2021 Title Shakeup Part 2: Our SERP Title Analysis Study

Intouch Solutions

NOVEMBER 30, 2021

URLs Examined: 860 URLs across 50 websites were examined; only URLs with all available data points were part of this research. Our research surfaced a “sweet spot” when it came to titles being pulled into Google’s search results. Our Methodology. Aim for title tags between 45 and 60 characters. Considerations . No real change here.

Branding

Branding Engineer Research Marketing

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Roots Analysis

NOVEMBER 3, 2023

As a starting point, the information on terminated, suspended and withdrawn trials was collated from clinicaltrials.gov and PubMed using relevant search keywords. Researchers are continuing to investigate the mechanisms of action of NAMPT inhibitors and are working to identify ways to improve their efficacy. Ronit holds a B.

Development

Development Drugs Trials FDA Approval

Grand Rounds January 19, 2024: Why Are Imaging RCTs Different? Lessons From Chest Pain Evaluation Trials (Pamela S. Douglas, MD, MACC, FASE, FAHA)

Rethinking Clinical Trials

JANUARY 23, 2024

Researchers also need to ask what is the optimal CTA intervention and should downstream care be required? I have not seen a payor fund a trial in this space. Speaker Pamela S. There are considerations for the flexibility of the intervention. Coronary CT angiography (CTA) may be the preferred test.

Trials

Trials Cardiology Clinical Trials Clinical Trials

Ep. 008 – Vlad Mkrtumyan Podcast Transcript

Pharma Marketing Network

OCTOBER 4, 2020

version right, so you got that kind of ultimate guide and then you got that 2.0 version in the book, there’s always more things to add, you know you can add an interview of yourself talking about the book.

Doctors

Doctors Doctor Marketing Packaging

Clinical Research Informer

Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)

Grand Rounds September 22, 2023: Integrating Community Health Workers into Team-Based, Early Childhood Preventative Care (Tumaini Rucker Coker, MD, MBA)

Trending Sources

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Grand Rounds August 19, 2022: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield, MD, MPH; Michelle Kelsey, MD)

Grand Rounds June 30, 2023: Decentralized Trials – From Guidance to Reality & What’s Left (Adrian Hernandez, MD, MHS; Pamela Tenaerts, MD, MPH; Craig Lipset, MPH)

Grand Rounds August 4, 2023: AI & ML: Want to Play a Game? (Eric Perakslis, PhD)

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Google’s 2021 Title Shakeup Part 2: Our SERP Title Analysis Study

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Grand Rounds January 19, 2024: Why Are Imaging RCTs Different? Lessons From Chest Pain Evaluation Trials (Pamela S. Douglas, MD, MACC, FASE, FAHA)

Ep. 008 – Vlad Mkrtumyan Podcast Transcript

Stay Connected